Log In
Print this Print this

AL 309

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
Description9 amino acid fragment of activity-dependent neuroprotective factor
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationNeuropathy
Indication DetailsTreat chemotherapy-induced peripheral neuropathy (CIPN); Treat diabetic peripheral neuropathy (DPN); Treat neurodegenerative diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today